Archives: Ipos

The global consumerware market, which includes a wide range of products used in the household for various purposes, such as kitchenware, tableware, cookware, cleaning tools and accessories etc, made from different materials like glass, plastic, bamboo, ceramic and others, has exhibited continuous growth over the years. It has grown at a CAGR of ~3.8% from USD 98 billion in CY 2019 to USD 114 billion in CY 2023 and is projected to reach USD 163 billion by CY 2029, growing at a CAGR of 6.3% between CY 2024 and CY 2029. The US remains the largest consumerware market with a 24.4% share in CY 2024, expected to reach USD 40.7 billion by CY 2029. India, despite holding a modest 2.7% market share, is poised for rapid growth with a projected CAGR of ~10.7% during the same period, driven by increasing demand for branded and aesthetically appealing products via organized retail and online platforms. All Time Plastics, which exports over 85% of its products and partners with globally reputed brands such as IKEA, Tesco, and Michael, is well-positioned to capitalize on this growing demand. To meet increasing demand, the company plans to expand its production capacity, utilizing a portion of the IPO proceeds to purchase equipment and machinery for its Manekpur facility. Additionally, to address the shift in consumer preference toward sustainable materials like glass and bamboo, the company is diversifying into bamboo-based product lines. Financially, the company has shown solid performance, with revenue rising from Rs. 4,434.9 million in FY23 to Rs. 5,581.7 million in FY25 and EBITDA growing at a CAGR of 17.5% from Rs. 726.5 million in FY23 to Rs. 1,002.2 million in FY25. The EBITDA margin for FY25 was 18.0% which was the second highest among primarily B2B players in the industry in India. PAT increased from Rs. 282.7 million in FY23 to Rs. 472.9 million in FY25. The company plans to use a portion of the IPO proceeds to reduce its existing debt of Rs. 1,017.6 million as of FY25. The company is currently valued at a PE ratio of 30.5x on the upper price band, based on FY25 earnings, which is comparatively lower than its peers. Given its strong fundamentals and long-term growth potential, we recommend a “SUBSCRIBE” rating for this issue from a long-term perspective.

JSW Cement Ltd. is a cement manufacturing company focused on manufacturing green cementitious products comprising blended cement (PSC), PPC, and GGBS. The company also manufactures OPC, clinker, and a range of allied cementitious products such as RMC, screened slag, construction chemicals and waterproofing compounds. JSW is the fastest-growing cement manufacturer in India in terms of growth in installed grinding capacity and sales volume. It is also the country’s largest manufacturer of GGBS. The company has long-term supply agreements with JSW Steel Limited and other partners, ensuring a steady supply of blast furnace slag for three to five years. Demand for GGBS is expected to grow at a CAGR of 14-15% from FY25 to FY30. Demand for cement from the company’s end-user sectors, like industrial and commercial buildings, rural housing, urban housing, and infrastructure, is expected to grow at a CAGR of 7.5-8.5% during the same period. JSW’s plants are strategically located across the southern, western, and eastern regions of India and are well-connected to their respective raw material sources and key consumption markets by road and/or rail, supporting efficient raw material sourcing and cost optimization. The company also benefits from strong sales and distribution network and a broad base of direct customers in India, enabling it to effectively serve both trade and non-trade segments. As part of the JSW Group, the company leverages synergies from the well-established “JSW” brand and the scale of the Group’s operations. Financially, the company’s EBITDA grew at a CAGR of 2.3% from FY23 to FY25, despite a marginal decline in revenue from Rs. 58,367.2 million in FY23 to Rs. 58,130.7 million in FY25, and its ROCE stood at 6.46%, 11.01% and 7.05% in FY23, FY24 and FY25, respectively. The company recently made a loss just in FY25, but the management expects to achieve breakeven in FY26 and return to profitability thereafter. Further, the company intends to use the amount raised from the IPO to set up a new integrated cement unit at Nagaur, Rajasthan, giving visibility for future revenue. Considering the company’s growth strategy and favourable industry dynamics, we recommend a “SUBSCRIBE” rating for this issue from a medium to long-term perspective. 

National Securities Depository Limited maintains a dominant position in India’s depository ecosystem, particularly in terms of the diversity and scale of asset classes held within demat accounts. The number of companies holding their securities in demat form has increased from 17,835 in FY17 to 79,773 in FY25, representing a 20.6% CAGR growth rate for NSDL, compared to 9,887 to 35,922 from FY17 to FY25, growing at a 17.5% CAGR for CDSL.  NSDL holds a higher share compared to CDSL among the two depositories in terms of the number of companies available for demat, the quantity, and value of securities held in demat form. NSDL maintains its focus on unlocking growth opportunities and deepening market reach by utilising its core competencies. The company plans to strengthen and modernise its IT infrastructure to improve operational efficiency, elevate service standards, and bolster resilience. Additionally, it aims to broaden its range of services, enhance its database management capabilities, and expand the market share of its payments bank division. On the financial front, the company has exhibited consistent growth. Between FY23 and FY25, revenue from operations rose from Rs. 10,219.8 million to Rs. 14,201.4 million. During the same period, profit after tax expanded from Rs. 2,348.1 million to Rs. 3,431.2 million, while EBITDA grew at a CAGR of 22.4%, increasing from Rs. 3,286.1 million to Rs. 4,929.4 million, demonstrating strong operational efficiency and profitability. The IPO is priced at a P/E of 46.6x on FY25 earnings at the upper end of the price band, which appears reasonable when compared to CDSL, currently trading at a P/E of 64.8x. We recommend a ‘SUBSCRIBE’ rating for the issue, supported by the company’s strong credit underwriting practices and prudent risk management framework.

Highway Infrastructure Ltd. is among the few toll operators in India to successfully implement Automatic Number Plate Recognition (ANPR)-based toll collection on the Delhi–Meerut Expressway. The company generates revenues in three segments. The company operates through three distinct business verticals: a) Tollway collection, b) EPC infrastructure, and c) Real estate. In its primary business vertical, Tollway collection, HIL operates and manages toll collection systems on highway projects procured through competitive bidding. The company remains committed to strengthening its core verticals, tollway collection and EPC infrastructure projects, which are expected to benefit from increasing government investments in road development and monetization initiatives. The company plans to actively bid for new projects under flagship programs like Bharatmala Pariyojana and Vision 2047, which aim to develop 50,000 km of access-controlled expressways. With experience in ANPR-based tolling systems and a footprint across 12 states, the company is well-positioned to scale operations and diversify geographically, reducing concentration risks. To broaden its revenue base, the company is exploring adjacent verticals: a) Widespread amenities (fuel stations, EV charging, eateries, etc., in partnership with NHAI), and b) HAM projects, which offer annuity-based, lower-risk revenue streams in highway development. Supported by the National Infrastructure Pipeline (over 9,000 projects) and initiatives like Make in India and PLI, these opportunities align with the company’s goal of sustainable, capital-efficient growth while managing diversification risks. The company has delivered robust financial performance, with revenue from operations growing at a CAGR of 4.4% between FY23 and FY25, reaching Rs. 4,957.1 million in FY25. More notably, PAT rose at a CAGR of 27.4% over the same period, demonstrating efficient cost management and operational leverage. EBITDA also witnessed a CAGR of 6.4%, underscoring improved profitability. At the upper end of the price band, the IPO is priced at a P/E of 20.5x FY25 earnings. While the valuation appears moderate to slightly rich relative to established peers, it is justified by the company’s strong execution track record, sectoral tailwinds, and robust growth outlook. Given its long-standing presence in toll operations, expanding footprint in EPC Infra, and potential for diversification into adjacencies, we recommend a ‘Subscribe’ rating for the issue.

India’s real estate industry is a major driver for economic growth and is expected to expand rapidly due to urbanization, infrastructure investments, digital innovation, and a tide of redevelopment projects, especially in metro cities like Mumbai. Sri Lotus Developers & Realty Ltd. has emerged as a prominent player in Mumbai’s ultra-luxury and luxury residential segments, specialising in the redevelopment of properties in the western suburbs. The company is well-positioned to capitalise on the growing trends in the Indian real estate industry. With its strong brand recall value, the company demands premium value for its properties. As of June 2025, Lotus has completed four projects, encompassing a developable area of 0.93 million sq. ft. across residential and commercial developments. The company has maintained a robust project pipeline, comprising five ongoing projects and 11 upcoming projects, which expands its presence beyond the western region into other micro-markets in the southern and central areas in Mumbai, such as Nepean Sea Road and Prabhadevi, as well as the eastern suburbs of Mumbai including Ghatkopar. Furthermore, the company’s asset-light model has resulted in a strong balance sheet and a net debt-free status. Financially, the company has demonstrated impressive growth across all fronts, with a revenue CAGR of 81.5% from FY23 to FY25, with revenue standing at Rs. 5,497 million, while the sales value grew from Rs. 1,987.8 million in FY23 to Rs. 4,629.3 million in FY25. The EBITDA grew at a CAGR of 267.8% from FY23 to FY25 to Rs. 2,890 million, with an EBITDA margin of 52.6%. The PAT grew from Rs. 168 million in FY23 to Rs. 2,279 million in FY25. The company is currently valued at an EV/EBITDA ratio of 25.4x on the upper price band, based on FY25 earnings, which is comparatively less than its peers. Given its proven track record of timely project completion, high brand recall value, premium pricing power, healthy project pipeline, ability to sell throughout the construction phase and strong financial performance, we recommend a “SUBSCRIBE” rating for this issue from a long-term perspective.

M&B Engineering Ltd., a leading player in the Pre-Engineered Buildings segment, offers comprehensive turn-key solutions that include project design, engineering, manufacturing and erection according to customer requirements across industrial and infrastructure segments. The company has delivered solutions to customers engaged in diverse sectors, including general engineering, manufacturing, food and beverages, warehousing and logistics, power, textiles, and railways. With a strong presence across diverse geographies, end-use applications, and project scales, M&B has built a strong track record that has helped it foster long-term relationships with both existing and potential customers. Pre-engineered construction has emerged as an innovative building method due to the increasing automation in the construction industry. The medium-term outlook for the Indian PEB industry is optimistic, with expected growth at a CAGR of 9.5-10.5% between FY25 and FY30, supported by investments in the industrial and infrastructure sectors, such as warehouses and logistics, as well as expressways. M&B’s offerings range from simple PEB structures to complex constructions. The strategic location of its manufacturing facilities enables the company to serve customers across India. Backed by engineering expertise and use of modern technology, M&B is able to efficiently meet customer requirements and expand its market presence. With a strong track record, extensive domain experience, established brand presence, and fully integrated capabilities across design, engineering, manufacturing, supply, and on-site project management, M&B is well-positioned to benefit from future growth opportunities in the PEB and steel roofing industry.  Financially, the company reported a revenue CAGR of 6% from FY23 to FY25, while PAT grew at an impressive CAGR of 53% during the same period. It also delivered a strong ROE and ROCE of 28.7% and 24.8% respectively, in FY25.  Based on FY25 earnings, the issue is valued at a P/E ratio of 25x based on the upper price band, which aligns well with its peers. We, thus, recommend a “SUBSCRIBE” rating for this issue.

Laxmi India Finance Limited (LIFL) is a non-deposit taking NBFC, specialising in secured lending to micro and small enterprises (MSMEs) across semi-urban and rural India. With 76.3% of its AUM and over 80% of FY25 revenue derived from MSME loans, the company has built a focused, asset-backed lending model targeting financially underserved but high-potential borrower segments. NBFCs focused on MSME lending are expected to grow their AUM at a CAGR of ~20–22% through FY27, driven by increasing formalisation, digitisation, and structural shifts in credit demand beyond metros. Laxmi India, with its deep-rooted presence, secured lending model, and digitised underwriting, is well placed to capitalise on this multi-year growth opportunity while maintaining prudent risk controls. The company has delivered strong financial performance, with revenue growing at a CAGR of 37.7% and profit after tax expanding at 50.1% between FY23 and FY25. Its AUM nearly doubled over the period, rising from Rs. 6,868 million to Rs. 12,770 million. Net Interest Margin improved to 9.7% in FY25 from 9.3% in FY23. Return ratios also strengthened, with RoAE increasing to 15.7% and RoATA rising to 3.0% in FY25, up from 12.6% and 2.5% in FY24, respectively. Potential concerns include a decline in CRAR (from 23.1% in FY23 to 20.8% in FY25), alongside a rise in GNPA by 49 bps to 1.07% and NNPA by 16 bps to 0.48%, indicating some moderation in capital buffers and marginal deterioration in asset quality. However, we believe that the company continues to show better resilience compared to its peers. Given its high-growth sectoral tailwinds and strong business execution, we remain optimistic about the company’s growth prospects. Based on its FY25 book value, the issue is valued at a P/B ratio of 3.2x at the upper price band, which we believe is fairly valued compared to its peers. Considering the above compelling factors, we recommend a “SUBSCRIBE” rating to this issue from a long-term perspective.

The company has achieved a dominant 20.8% revenue market share in India’s growing video surveillance industry (as of FY25), positioning itself well to sustain leadership through a combination of scale, technological innovation, and deep market penetration. Its integrated business model spanning product development, manufacturing, distribution, and services enables it to serve both enterprise and consumer markets efficiently. The CP PLUS brand enjoys strong recall and trust, supported by a retail network of over 1,000 distributors and 2,100 system integrators, a presence in 550 cities, and dedicated experience centres and Galaxy stores that continue to expand, especially across Tier II and III regions. The company plans to scale up its manufacturing operations to produce a larger number of units, catering to the growing demand for its product offerings. The Kadapa facility is well-positioned to facilitate this growth, as it has scope for capacity expansion from its current installed capacity of 17.20 million units per annum, as of March 31, 2025. On the financial front, the company reports revenue EBITDA/PAT at a CAGR of 16.7%, 24.1%, and 80.1%, respectively, which has demonstrated stable and improving performance over the past three years. The company’s backwards integration into housing production, combined with a robust quality assurance process, provides better margin control and product reliability. Its in-house R&D capabilities, augmented by strategic collaborations, have enabled the launch of AI-powered products, cloud-based services, and vertical-specific solutions for sectors including real estate, BFSI, education, law enforcement, and public infrastructure. The company is also strategically doubling down on retail-led growth, service-oriented enterprise solutions, and expanding its product ecosystem through the integration of AI and IoT. With a strong foothold in India, certification-aligned manufacturing, and digital-first applications, it is well-positioned to evaluate global expansion and provide long-term growth visibility for the business. The issue is valued at a P/E ratio of 20.4x based on the upper price band, using FY25 earnings which is at deemed fair.  We, thus, recommend a “SUBSCRIBE” rating for this issue.

Shanti Gold International Ltd., one of the leading manufacturers of high-quality 22kt CZ casting gold jewellery, specializes in the design and production of all types of gold jewellery. The company offers a wide range of intricately designed, high-quality pieces and has a presence in both domestic and international markets. Its fully integrated in-house manufacturing facility enables the company to manage key functions and maintain product quality in line with customer standards. SGIL has long-standing relationships with its clients and is actively working to expand its global footprint, particularly in the USA and the UAE. The Indian jewellery market is expected to grow at a CAGR of 9.7% between CY23 and CY29. This surge in demand can be attributed to the growing middle-class population and rising disposable income levels. As more individuals experience higher income, they become more capable of affording luxury items like gold jewellery. For this segment, gold jewellery is seen not only as a status symbol and a reflection of an improved lifestyle but also as a valuable investment. SGIL focuses on designing and manufacturing a wide variety of jewellery to cater to diverse regional and international preferences. This strategy is expected to help the company build partnerships, expand its distribution network, and adapt its offerings to evolving market trends. Financially, the company has demonstrated robust growth, with revenue growing at a CAGR of 27.6% between FY23 and FY25. EBITDA and net profit grew at CAGRs of 46.5% and 67.9%, respectively, during the same period. On the upper band, the issue is priced at a P/E of 19.2x based on FY25 earnings, which aligns well with its peers. Given SGIL’s strategic international expansion and established domestic client base, we recommend a “SUBSCRIBE” rating for the issue with a medium to long-term investment perspective.  

Anthem Biosciences Limited is a leading innovation-driven Indian CRDMO with fully integrated capabilities across the drug development value chain. The company’s core strategic focus has been on early investments in building integrated capabilities across both small molecules and biologics (large molecules), enabling it to serve the entire drug development value chain, from discovery to commercial-scale manufacturing. The company focuses on innovation in advanced technologies such as ADCs, RNAi, peptides, and biotransformation, providing a distinct edge. It is the only Indian CRDMO with fully integrated capabilities across both New Chemical Entities and New Biological Entities, allowing it to deliver comprehensive services from discovery to commercialization. The company has leveraged its early-mover advantage in these platforms to establish high entry barriers and differentiated positioning. Furthermore, Anthem Biosciences has complemented its scientific capabilities with technology-led manufacturing techniques such as flow chemistry, biotransformation, and green chemistry, which improve sustainability and enhance process economics. The company also employs a customer-centric strategy that emphasizes long-term relationships with innovative pharmaceutical and biotech companies. Its ability to support over 675 clients and contribute to the lifecycle of 10 commercialized molecules (which contributed ~54% to FY25 revenue) reflects its trusted partner status. On the financial front, the company has demonstrated stable and improving performance over the past three years, supported by strong operating performance and capital efficiency. In FY25, the company reported healthy annual revenue growth, driven by scale-up across its integrated CRDMO platforms and strong client demand for both small and large molecule development. Additionally, the company’s prudent capital allocation and focus on expanding high-margin service verticals have enabled it to deliver industry-leading EBITDA margins (36.8% in FY25) and strong ROCE. With industry-leading growth, superior return ratios, differentiated capabilities in high-barrier segments, and strong global customer relationships, Anthem Biosciences stands out as a premium CRDMO player. The issue is valued at a P/E ratio of 70.9x based on the upper price band, using FY25 earnings. We thus  recommend a “SUBSCRIBE” rating for this issue